NextGen Healthcare (NXGN) Tops Q4 EPS by 2c, Revenues Beat; Offers FY22 EPS Guidance Below Consensus, FY22 Revs. Mid-Point Outlook Above Consensus

Go back to NextGen Healthcare (NXGN) Tops Q4 EPS by 2c, Revenues Beat; Offers FY22 EPS Guidance Below Consensus, FY22 Revs. Mid-Point Outlook Above Consensus
Nexgen Biofuels (NASDAQ: NXGN) Delayed: 23.94 --0 (-0%)
Previous Close $23.94    52 Week High $0.79 
Open $0.27    52 Week Low $0.79 
Day High $23.94    P/E 798.00 
Day Low $23.94    EPS $0.03 
Volume 6,866